Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
6.50
+0.11 (1.72%)
At close: Aug 29, 2025, 4:00 PM
6.61
+0.11 (1.69%)
After-hours: Aug 29, 2025, 4:14 PM EDT

Indaptus Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2020
Net Income
-16.96-15.02-15.42-14.32-7.71-3.58
Upgrade
Depreciation & Amortization
-00000
Upgrade
Loss (Gain) From Sale of Assets
----0.02--
Upgrade
Stock-Based Compensation
1.172.312.972.961.510.14
Upgrade
Other Operating Activities
0.79--0.43-0.11--
Upgrade
Change in Accounts Payable
-0.010.47-0.68-1.15-4.240.11
Upgrade
Change in Other Net Operating Assets
0.04-0.080.16-0.43-0.850
Upgrade
Operating Cash Flow
-14.97-12.32-13.41-13.08-11.29-3.32
Upgrade
Capital Expenditures
-----0-
Upgrade
Sale of Property, Plant & Equipment
---0.170.45-
Upgrade
Investment in Securities
--17.14-16.6--
Upgrade
Investing Cash Flow
--17.14-16.430.45-
Upgrade
Issuance of Common Stock
9.195.51--0.39-
Upgrade
Other Financing Activities
-1.08-0.76--47.951.16
Upgrade
Financing Cash Flow
13.834.75--48.341.16
Upgrade
Net Cash Flow
-1.14-7.583.74-29.5137.49-2.16
Upgrade
Free Cash Flow
-14.97-12.32-13.41-13.08-11.29-3.32
Upgrade
Free Cash Flow Per Share
-33.11-36.88-44.68-44.32-77.31-47.87
Upgrade
Cash Income Tax Paid
000000
Upgrade
Levered Free Cash Flow
-8.96-6.86-7.77-7.07-1.99-0.82
Upgrade
Unlevered Free Cash Flow
-8.96-6.86-7.77-7.07-1.99-0.82
Upgrade
Change in Working Capital
0.030.39-0.52-1.58-5.090.12
Upgrade
Updated Aug 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q